Minerva Neurosciences, Inc. (NERV) Shareholders’ equity 2017–2024
Minerva Neurosciences, Inc. (NERV) shareholders’ equity at each fiscal year-end, per SEC filings.
-$25.7MFY2024 · since FY2017: $131.6M → -$25.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$25.7M | +9.7% |
| FY2023 | -$28.5M | -42.1% |
| FY2022 | -$20.0M | -351.1% |
| FY2021 | $8.0M | -84.9% |
| FY2020 | $52.7M | +89.6% |
| FY2019 | $27.8M | -69.2% |
| FY2018 | $90.3M | -31.4% |
| FY2017 | $131.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice